Klinik für Psychiatrie und Psychotherapie
  1. Startseite LMU Klinikum
  2. Psychiatrie und Psychotherapie
  3. Forschung/Research
  4. Supported Studies

Supported Studies

Supported by DFG - Deutsche Forschungsgemeinschaft

  • CANNA-TICS – Randomised, multicentre, double-blind, placebo-controlled study to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders
  • Treatment of auditory hallucinations in schizophrenia with bilateral theta burst stimulation (TBS-AH)

Supported by German Bundesministerium für Bildung und Forschung

  • ONLINE-TICS - Multicentre, prospective, randomised, observer-blind clinical study on the efficacy of iCBIT in patients with Tourette Syndrome and tic disorders

  • The DiSCoVeR Project: Examining the synergistic effects of a cognitive control videogame and self-administered non-invasive brain stimulation on alleviating depression (DiSCoVeR)
  • Treatment of major depressive disorder with bilateral theta burst stimulation (TBS-D)
  • Transcranial direct current stimulation (tDCS) as a treatment for major depression (Depression DC)
  • Augmentation of cognitive-behavioural psychotherapy with prefrontal direct current stimulation in major depression (PsychotherapyPlus)
  • Pathophysiology-specific development of transcranial direct current stimulation (tDCS) of the prefrontal cortex – studies on functional MRT connectivity

Supported by ERA-NET NEURON

  • The DiSCoVeR Project: Examining the synergistic effects of a cognitive control videogame and self-administered non-invasive brain stimulation on alleviating depression (DiSCoVeR)

Supported by DLR

  • Transcranial direct current stimulation (tDCS) as a treatment for major depression (Depression DC)

  • Augmentation of cognitive-behavioural psychotherapy with prefrontal direct current stimulation in major depression (PsychotherapyPlus)
  • Pathophysiology-specific development of transcranial direct current stimulation (tDCS) of the prefrontal cortex – studies on functional MRT connectivity

Supported by ERA PerMed

  • Validation of a Single-Subject Treatment Outcome Predictor for Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Negative Symptoms in Schizophrenia (PREMISS)